![CLOBETASOL PROPIONATE GEL, 0.05%CLOBETASOL PROPIONATE CREAM USP, 0.05%CLOBETASOL PROPIONATE OINTMENT USP, 0.05%(Potency expressed as clobetasol propionate) CLOBETASOL PROPIONATE GEL, 0.05%CLOBETASOL PROPIONATE CREAM USP, 0.05%CLOBETASOL PROPIONATE OINTMENT USP, 0.05%(Potency expressed as clobetasol propionate)](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=ointlabel15g-02.jpg&id=507404)
CLOBETASOL PROPIONATE GEL, 0.05%CLOBETASOL PROPIONATE CREAM USP, 0.05%CLOBETASOL PROPIONATE OINTMENT USP, 0.05%(Potency expressed as clobetasol propionate)
![John Libbey Eurotext - European Journal of Dermatology - Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo John Libbey Eurotext - European Journal of Dermatology - Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo](http://www.jle.com/e-docs/00/04/0A/DF/texte_alt_jleejd00056_gr1.jpg)
John Libbey Eurotext - European Journal of Dermatology - Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo
![Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification – JCAD | The Journal of Clinical and Aesthetic Dermatology Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/DelRossoFigure4.jpg)
Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification – JCAD | The Journal of Clinical and Aesthetic Dermatology Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/DelRossoFigure5.jpg)
Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Topical Clobetasol Propionate Treatment and Cutaneous Adverse Effects in Patients With Early-Stage Mycosis Fungoides: An Observational Study | MDedge Dermatology Topical Clobetasol Propionate Treatment and Cutaneous Adverse Effects in Patients With Early-Stage Mycosis Fungoides: An Observational Study | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/CT105005027_e_Fig1AB.jpg)